Results of blood tests
| . | Sex . | Age, y . | WBC count, × 109/L . | RBC count, × 1012/L . | Hemoglobin level,g/L . | Platelet count,× 109/L . | V716F, % . | Diagnosis . |
|---|---|---|---|---|---|---|---|---|
| Entire samples, mean ± SD | — | 48.6 ± 16.6 | 7.39 ± 3.69 | 4.26 ± 1.19 | 128.3 ± 23.4 | 213.4 ± 84 | — | — |
| JAK2V617F positive, mean ± SD | — | 55.6 ± 13.6 | 9.44 ± 5.07 | 4.40 ± 0.58 | 132 ± 19 | 272 ± 99.6 | — | — |
| Sample no. | ||||||||
| 224 | M | NA | 4* | 3.02* | 88* | 92* | 41 | Kidney failure |
| 500 | F | NA | NA | NA | NA | NA | 86 | NA |
| 548 | M | 37 | 11.1† | 3.69* | 101* | 382† | < 5 | Stomach cancer |
| 832 | M | 58 | 8.8 | 5.44 | 156 | 249 | < 5 | Pneumonia |
| 860 | F | NA | 4.7 | 4.67 | 145 | 202 | < 5 | NA |
| 896 | F | NA | NA | NA | NA | NA | 57 | NA |
| 1255 | M | NA | 4.6 | 3.74* | 99* | 147 | 48 | NA |
| 1381 | M | NA | 10 | 4.79 | 141 | 432† | < 5 | NA |
| 1591 | M | 41 | 20.1† | 3.74* | 118* | 216 | < 5 | Arterial and venous thrombosis |
| 1644 | M | NA | 4.7 | 4.82 | 130 | 196 | < 5 | NA |
| 1648 | F | NA | 14.3† | 4.27 | 136 | 256 | < 5 | NA |
| 1651 | F | NA | 4* | 5.17 | 105* | 297 | < 5 | NA |
| 1695 | M | NA | 15.2† | 5.39 | 166† | 521† | 7 | NA |
| 1909 | M | 61 | 8.4 | 4.33 | 123* | 275 | < 5 | NA |
| 2026 | M | 45 | 7.3 | 4.58 | 148 | 170 | < 5 | NA |
| 2066 | F | 74 | 8.1 | 4.85 | 157 | 295 | < 5 | NA |
| 2109 | F | 69 | 9 | 4.38 | 129 | 367† | < 5 | NA |
| 2281 | F | 68 | 6.6 | 3.88 | 123 | 206 | < 5 | NA |
| 2304 | F | NA | 6 | 4.46 | 134 | 372 | < 5 | NA |
| 2335 | M | 44 | 3.1* | 4.63 | 145 | 174 | < 5 | Hemangioma |
| 2629 | F | NA | 9.2 | 4.05 | 121 | 387† | 30 | NA |
| 2655 | F | NA | 7.4 | 4.6 | 143 | 279 | < 5 | NA |
| 2773 | M | 53 | 4.5 | 4.77 | 143 | 301† | < 5 | Coronary heart disease |
| 2781 | M | 54 | 15.6† | 4.75 | 141 | 454† | 8 | NA |
| 2823 | M | 43 | 6.1 | 4.94 | 154 | 234 | < 5 | Diabetes |
| 2881 | M | NA | 9.5 | 3.2* | 112* | 197 | < 5 | ND |
| 2908 | M | 38 | 10.7† | 4.41 | 146 | 179 | < 5 | Cervical spine injury |
| 2926 | M | 66 | 9 | 4.04 | 124 | 246 | < 5 | Diabetes |
| 2943 | F | 65 | 5.8 | 4.05 | 132 | 190 | < 5 | Coronary heart disease |
| 2944 | F | 48 | 18.2† | 4.27 | 125 | 464† | 45 | ND |
| 3015 | F | 65 | 10.5† | 3.97 | 117 | 236 | 11 | Arteriosclerosis |
| 3042 | M | 50 | 3.5* | 4.48 | 124 | 145 | < 5 | Pneumonia |
| 3243 | M | 45 | 26.2† | 4.45 | 132 | 273 | < 5 | ND |
| 3714 | M | 73 | 12.6† | 4.9 | 151 | 254 | 8 | Cerebral ischemia |
| 3910 | F | 82 | 9.7 | 5.07 | 163 | 306† | 46 | ND |
| 3981 | M | 34 | 12.2† | 4.99 | 136 | 216 | < 5 | Cerebral infarction |
| 4120 | F | 66 | 9.6 | 3.39 | 105 | 310† | 10 | Fracture |
| . | Sex . | Age, y . | WBC count, × 109/L . | RBC count, × 1012/L . | Hemoglobin level,g/L . | Platelet count,× 109/L . | V716F, % . | Diagnosis . |
|---|---|---|---|---|---|---|---|---|
| Entire samples, mean ± SD | — | 48.6 ± 16.6 | 7.39 ± 3.69 | 4.26 ± 1.19 | 128.3 ± 23.4 | 213.4 ± 84 | — | — |
| JAK2V617F positive, mean ± SD | — | 55.6 ± 13.6 | 9.44 ± 5.07 | 4.40 ± 0.58 | 132 ± 19 | 272 ± 99.6 | — | — |
| Sample no. | ||||||||
| 224 | M | NA | 4* | 3.02* | 88* | 92* | 41 | Kidney failure |
| 500 | F | NA | NA | NA | NA | NA | 86 | NA |
| 548 | M | 37 | 11.1† | 3.69* | 101* | 382† | < 5 | Stomach cancer |
| 832 | M | 58 | 8.8 | 5.44 | 156 | 249 | < 5 | Pneumonia |
| 860 | F | NA | 4.7 | 4.67 | 145 | 202 | < 5 | NA |
| 896 | F | NA | NA | NA | NA | NA | 57 | NA |
| 1255 | M | NA | 4.6 | 3.74* | 99* | 147 | 48 | NA |
| 1381 | M | NA | 10 | 4.79 | 141 | 432† | < 5 | NA |
| 1591 | M | 41 | 20.1† | 3.74* | 118* | 216 | < 5 | Arterial and venous thrombosis |
| 1644 | M | NA | 4.7 | 4.82 | 130 | 196 | < 5 | NA |
| 1648 | F | NA | 14.3† | 4.27 | 136 | 256 | < 5 | NA |
| 1651 | F | NA | 4* | 5.17 | 105* | 297 | < 5 | NA |
| 1695 | M | NA | 15.2† | 5.39 | 166† | 521† | 7 | NA |
| 1909 | M | 61 | 8.4 | 4.33 | 123* | 275 | < 5 | NA |
| 2026 | M | 45 | 7.3 | 4.58 | 148 | 170 | < 5 | NA |
| 2066 | F | 74 | 8.1 | 4.85 | 157 | 295 | < 5 | NA |
| 2109 | F | 69 | 9 | 4.38 | 129 | 367† | < 5 | NA |
| 2281 | F | 68 | 6.6 | 3.88 | 123 | 206 | < 5 | NA |
| 2304 | F | NA | 6 | 4.46 | 134 | 372 | < 5 | NA |
| 2335 | M | 44 | 3.1* | 4.63 | 145 | 174 | < 5 | Hemangioma |
| 2629 | F | NA | 9.2 | 4.05 | 121 | 387† | 30 | NA |
| 2655 | F | NA | 7.4 | 4.6 | 143 | 279 | < 5 | NA |
| 2773 | M | 53 | 4.5 | 4.77 | 143 | 301† | < 5 | Coronary heart disease |
| 2781 | M | 54 | 15.6† | 4.75 | 141 | 454† | 8 | NA |
| 2823 | M | 43 | 6.1 | 4.94 | 154 | 234 | < 5 | Diabetes |
| 2881 | M | NA | 9.5 | 3.2* | 112* | 197 | < 5 | ND |
| 2908 | M | 38 | 10.7† | 4.41 | 146 | 179 | < 5 | Cervical spine injury |
| 2926 | M | 66 | 9 | 4.04 | 124 | 246 | < 5 | Diabetes |
| 2943 | F | 65 | 5.8 | 4.05 | 132 | 190 | < 5 | Coronary heart disease |
| 2944 | F | 48 | 18.2† | 4.27 | 125 | 464† | 45 | ND |
| 3015 | F | 65 | 10.5† | 3.97 | 117 | 236 | 11 | Arteriosclerosis |
| 3042 | M | 50 | 3.5* | 4.48 | 124 | 145 | < 5 | Pneumonia |
| 3243 | M | 45 | 26.2† | 4.45 | 132 | 273 | < 5 | ND |
| 3714 | M | 73 | 12.6† | 4.9 | 151 | 254 | 8 | Cerebral ischemia |
| 3910 | F | 82 | 9.7 | 5.07 | 163 | 306† | 46 | ND |
| 3981 | M | 34 | 12.2† | 4.99 | 136 | 216 | < 5 | Cerebral infarction |
| 4120 | F | 66 | 9.6 | 3.39 | 105 | 310† | 10 | Fracture |
Normal ranges: WBC count, 4.5 × 109/L-10 × 109/L; RBC count, 4 × 1012/L-5.5 × 1012/L (male) or 3.5 × 1012/L-5.5 × 1012/L (female); hemoglobin level, 126-160 g/L (male) or 110–150 g/L (female); platelet count, 100 × 109/L-300 × 109/L.
WBC indicates white blood cell; RBC, red blood cell; —, not applicable; NA, not available; ND, not determined or no diagnosis to make.
Samples with blood level below normal.
Samples with blood level above normal.